Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease

Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease

Source: 
Fierce Biotech
snippet: 

Immunic can no longer keep all its balls in the air. Rather than keep advancing on three fronts, the firm has decided to deprioritize development in psoriasis and castration-resistant prostate cancer and throw its remaining resources at two other programs.